Search clinical trials for: (N1, N3-bis(2- mercaptoethyl)isophthalamide)
Total 4 results
-
EmeraMedRecruiting
-
EmeraMedNBMI Science ABCompletedMercury PoisoningEcuador
-
EmeraMedCompletedBeta Thalassemia MajorAlbania
Sponsors and Collaborators
- CellMaxLife
- Colorado Childrens Hospital
- Jorge Orduña-Valls
- Institute of Cancer Research (ICR), United Kingdom
- Ringerike sykehus, Vestre Viken HF
- Holger Dressel
- Clinical Oncology department. Elmansoura University.
- Amira Hussin Hussin Mohammed
- Monroe Carell Jr. Children's Hospital at Vanderbilt
- Tarek Alsaied
- Secretariat of Public Education (SEP)
- Azienda Unità Sanitaria Locale Reggio Emilia
- Camille Levy
- Craving Change
- Healthy Life
- First People's Hospital of Shenyang
- Giovanni Mirabella
- Facultad de Estudios Superiores Aragón UNAM
- Innovative Therapies, Inc.
- Ozden Gokcek
- View Full List
Medical Conditions
- Homologous Recombination Deficient Solid Tumors
- Angiotensin-Converting Enzyme Inhibitors
- Drainage Procedure
- Acute Myelogenous Leukemia (AML or ANLL)
- Impulse-Control Disorders
- Postoperative Analgesic Demand
- Rectal Adenocarcinoma
- Post-operative Intercostal Neuralgia
- Peripheral Neuropathy Associated With Anti-myelin Associated Glycoprotein Antibodies (Anti-MAG Neuropathy)
- Triple Negative Breast Cancer, TNBC
- Skin and Subcutaneous Tissue Infection
- Human Herpes Virus-6 Infection
- Ventilator Induced Diaphragm Dysfunction
- Emergency Geriatric Care
- MINI MENTAL STATE EXAMINATION TEST
- Established Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD Risk
- CYP2C19 Poor
- Asthma, Allergic
- Ascorbic Acid
- Body Height
- View Full List
Drug Interventions
- Ascorbic Acid
- AZD7325
- RBS2418
- BMS-770767
- Octreotide
- Enfuvirtide-intensified HAART
- Leucovorin
- Trastuzumab
- GW-1000-02
- Bevacizumab standard of care
- Standard of care
- Luliconazole Cream 1% - 2 wks
- Antithymocyte globulin (Rabbit)
- Tenecteplase
- AMT-101 (oral)
- Topical Solution
- Fluvastatin
- Xenon
- Prolonged release (PR) OROS methylphenidate 72 mg
- Background regimen (BR) for MDR-TB (multi-drug resistant tuberculosis)
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Chile
- Contract Research Organizations in Georgia
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in South Korea
- Contract Research Organizations in Spain
- Contract Research Organizations in Zimbabwe
- CRO list by country